Jaw Necrosis Risk in Cancer Patients on Zoledronic Acid Varies With Dosing Jaw Necrosis Risk in Cancer Patients on Zoledronic Acid Varies With Dosing

In patients treated with zoledronic acid for bone metastases, the risk of osteonecrosis of the jaw was associated with cancer type, oral health and dosing frequency, researchers found in a recent study.Reuters Health Information
Source: Medscape Orthopaedics Headlines - Category: Orthopaedics Tags: Dental & Oral Health News Source Type: news